Nothing Special   »   [go: up one dir, main page]

REINsMoEN et al., 1992 - Google Patents

DIFFERENTIATION OF CLASS I-AND CLASS II-DIRECTED DONOR-SPECIFIC ALLOREACTIVITY IN BRONCHOALVEOLAR LAVAGE LYMPHOCYTES FROM LUNG …

REINsMoEN et al., 1992

Document ID
13735943082506422155
Author
REINsMoEN N
Bolman R
Savik K
Butters K
Hertz M
Publication year
Publication venue
Transplantation

External Links

Snippet

Previous studies have demonstrated that donor antigen-specific primed-lymphocyte-test (PLT) reactivity of bronchoalveolar lavage lymphocytes is strongly associated with acute pulmonary rejection and with obliterative bronchiolitis (OB); however, a systematic analysis …
Continue reading at journals.lww.com (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Similar Documents

Publication Publication Date Title
REINsMoEN et al. DIFFERENTIATION OF CLASS I-AND CLASS II-DIRECTED DONOR-SPECIFIC ALLOREACTIVITY IN BRONCHOALVEOLAR LAVAGE LYMPHOCYTES FROM LUNG TRANSPLANT RECIPIENTS1
Semenzato et al. Lung T cells in hypersensitivity pneumonitis: phenotypic and functional analyses.
Mayer et al. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.
Ligthart et al. The expanded null cell compartment in ageing: increase in the number of natural killer cells and changes in T-cell and NK-cell subsets in human blood.
Ligthart et al. Natural killer cell function is not diminished in the healthy aged and is proportional to the number of NK cells in the peripheral blood.
Parhar et al. Suppression of lymphocyte alloreactivity by early gestational human decidua: I. Characterization of suppressor cells and suppressor molecules
Reznik et al. Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome
Rabellino et al. Receptors for C3 and IgG on macrophage, neutrophil and eosinophil colony cells grown in vitro
McIntyre et al. Trophoblast modulation of maternal allogeneic recognition.
Mojcik et al. Characterization of RT6 bearing rat lymphocytes: I. Ontogeny of the RT6+ subset
Molajoni et al. Mechanism of liver allograft rejection: the indirect recognition pathway
De Berardinis et al. The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+.
Hunt et al. Expression of histocompatibility antigens, transferrin receptors, intermediate filaments, and alkaline phosphatase by in vitro cultured rat placental cells and rat placental cells in situ
Preffer et al. Two-color flow cytometry and functional analysis of lymphocytes cultured from human renal allografts: identification of a Leu-2+ 3+ subpopulation.
Bagnasco et al. Graves' disease: phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyroid
Pinto et al. Loss of CD45RA and gain of CD45RO after in vitro activation of lymphocytes from HIV-infected patients.
Lanzavecchia et al. Human T cell lines with antigen specificity and helper activity
Becker et al. Characterization of normal human lung lymphocytes and interleukin-2-induced lung T cell lines
Andrews et al. The limited immunocompetence of thymocytes within murine thymic nurse cells
Ballas et al. Lymphokine-activated killer (LAK) cells. III. Characterization of LAK precursors and susceptible target cells within the murine thymus.
Lazarovits et al. CD7–T cells in rheumatoid arthritis
Garraud et al. Effect of blood storage on lymphocyte subpopulations
Stevenson et al. Characterization of purified cryopreserved human monocyte function in assays of superoxide production, accessory cell function, chemotaxis, and in fluorescent cell sorter analysis
Padovan et al. Immunophenotyping of lymphocyte subsets in bronchoalveolar lavage fluid Comparison of flow cytometric and immunocytochemical techniques: Comparison of flow cytometric and immunocytochemical techniques
Winter et al. Distinct phenotypes of infiltrating cells during acute and chronic lung rejection in human heart-lung transplants